Asta

아스타 · 246720

Health Care Pharmaceuticals · KOSDAQ

Small-cap

Market cap US$72.1M (₩99.4B)

Overview

Asta makes mass spectrometry instruments, analytical devices that identify unknown substances by measuring the mass of molecules, for both medical and industrial use, and supplies them to hospitals, clinics, and manufacturers in display, battery, and semiconductor industries.

Its medical instruments help laboratories identify bacteria and fungi from patient samples, while its industrial instruments are used for quality-control inspection on factory production lines. Listed on KOSDAQ, Korea's tech-focused small-cap board, the company has expanded its product portfolio from medical microbiology diagnostics into industrial process analysis, with distinct instrument lines targeting display, electric-vehicle battery, and semiconductor applications.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$1.9M

▼ −22.6% YoY

Operating profit · FY2025

−US$1.9M

Loss narrowed

Net income · FY2025

−US$2.4M

Loss narrowed

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$2.3M(₩3.1B)	US$2.4M(₩3.4B)	US$1.9M(₩2.6B)
Operating profit	−US$2M(−₩2.7B)	−US$2.9M(−₩4B)	−US$1.9M(−₩2.6B)
Net income	−US$2M(−₩2.8B)	−US$2.8M(−₩3.9B)	−US$2.4M(−₩3.3B)

Revenue

FY2023US$2.3M
FY2024US$2.4M
FY2025US$1.9M

Operating profit

FY2023−US$2M
FY2024−US$2.9M
FY2025−US$1.9M

Net income

FY2023−US$2M
FY2024−US$2.8M
FY2025−US$2.4M

Key ratios (FY2025)

ROE

-35.8%

Debt/Eq

67.9%

Op. margin

-99.8%

Net margin

-127.3%

Rev. YoY

▼ −22.6%

Price charts coming soon

Interactive price history isn't here yet. Would you use it?